ingestion of Gaxilose
clinical validation of Xylose
consolidation of Venter Pharma
Biomarker of intestinal diseases
INtestinal PATHologies MARKinPATH global innovation project
management of intestinal pathologies
use
commercialization of clinical solutions
regular clinical practice
hypolactasia diagnosis
measurement of Xylose
Hydrogen breath test
Lactose tolerance test
development
HBT
relevant Intellectual Capital
tests available
technical features
years
extensive background
sensitivity
LTT
specificity
advanced research
necessary growth
respect
alternative methods
healthcare
innovative SME
adverse effects
pharmaceutical market
efficient health expenditure
field
demand
resulting solution
technologies
paediatrics population
patient
adults